ReviewFoods (Basel, Switzerland)2026
Emerging Trends in Nanotechnology and AI-Driven Valorization of Agro-Industrial Waste in Circular Bioeconomy for Production of Biostimulants.
Review in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global agricultural sector faces the dual challenge of increasing productivity while mitigating environmental impacts caused by synthetic agrochemicals and massive agro-industrial waste. This review examines the transition to "Biostimulants 4.0," a circular economy paradigm driven by the valorization of biomass residues into high-value biological inputs through nanotechnology and Artificial Intelligence (AI). Our analysis highlights that green extraction methods, specifically enzymatic hydrolysis, preserve bioactive integrity and reduce carbon emissions by up to 23.2 times compared to synthetic nitrogen production. Furthermore, waste-derived formulations and nanoscale smart-delivery systems dramatically enhance crop performance; for instance, chitosan nanoparticles can achieve up to a 471% increase in specific growth metrics through sustained-release pathways. To move the industry beyond empirical trial-and-error, the integration of AI-driven predictive models now achieves up to 87% accuracy in forecasting biostimulant efficacy. Finally, we contrast global regulatory frameworks and evaluate the monetization of biostimulant-driven carbon sequestration, capable of generating high-integrity credits priced up to $35 per tonne, as a critical economic pathway to accelerate commercial adoption and incentivize a resilient, decarbonized agricultural system.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.